昊華能源(601101.SH)控股股東增持0.25%股份 擬再增持1%至2%股份
格隆匯3月4日丨昊華能源(601101.SH)公佈,公司控股股東京能集團於2020年3月4日,通過上海證券交易所交易系統增持昊華能源股票300.238萬股,增持股份佔公司總股本的0.25%。本次增持前,京能集團持有公司股票7.48億股,佔公司總股本的62.30%;本次增持完成後,京能集團共持有公司股票7.51億股,佔公司總股本的62.55%。
基於對昊華能源未來持續穩定發展的信心,京能集團擬自本次實施增持行為發生之日的6個月內,以京能集團名義繼續通過上海證券交易所交易系統(或其他方式)增持公司股份,累計增持比例佔公司已發行總股份的1%(含)至2%(不含)之間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.